Anticancer activity of curcumin and its analogues: preclinical and clinical studies

A Allegra, V Innao, S Russo, D Gerace… - Cancer …, 2017 - Taylor & Francis
Curcumin has been shown to have a wide variety of therapeutic effects, ranging from anti-
inflammatory, chemopreventive, anti-proliferative, and anti-metastatic. This review provides …

Bone metastasis of breast cancer

RK Tahara, TM Brewer, RL Theriault… - Breast Cancer Metastasis …, 2019 - Springer
Bone is the most common site of metastasis for breast cancer. Bone metastasis significantly
affects both quality of life and survival of the breast cancer patient. Clinically, complications …

Bioactivity of turmeric-derived curcuminoids and related metabolites in breast cancer

LE Wright, JB Frye, B Gorti… - Current …, 2013 - ingentaconnect.com
While the chemotherapeutic effect of curcumin, one of three major curcuminoids derived
from turmeric, has been reported, largely unexplored are the effects of complex turmeric …

[HTML][HTML] Therapeutic potential and limitations of curcumin as antimetastatic agent

P Dytrych, Z Kejík, J Hajduch, R Kaplánek… - Biomedicine & …, 2023 - Elsevier
Abstract Treatment of metastatic cancer is one of the biggest challenges in anticancer
therapy. Curcumin is interesting nature polyphenolic compound with unique biological and …

[HTML][HTML] Murine models of breast cancer bone metastasis

LE Wright, PD Ottewell, N Rucci, O Peyruchaud… - BoneKEy …, 2016 - ncbi.nlm.nih.gov
Bone metastases cause significant morbidity and mortality in late-stage breast cancer
patients and are currently considered incurable. Investigators rely on translational models to …

Toward regulatory effects of curcumin on transforming growth factor-beta across different diseases: a review

M Ashrafizadeh, A Zarrabi, K Hushmandi… - Frontiers in …, 2020 - frontiersin.org
Immune response, proliferation, migration and angiogenesis are juts a few of cellular events
that are regulated by transforming growth factor-β (TGF-β) in cells. A number of studies have …

Molecular mechanisms of bone metastasis and associated muscle weakness

DL Waning, TA Guise - Clinical Cancer Research, 2014 - AACR
Bone is a preferred site for breast cancer metastasis and leads to pathologic bone loss due
to increased osteoclast-induced bone resorption. The homing of tumor cells to the bone …

Curcumin, but not curcumin-glucuronide, inhibits Smad signaling in TGFβ-dependent bone metastatic breast cancer cells and is enriched in bone compared to other …

AG Kunihiro, JA Brickey, JB Frye, PB Luis… - The Journal of nutritional …, 2019 - Elsevier
Breast cancer (BCa) bone metastases (BMETs) drive osteolysis via a feed-forward loop
involving tumoral secretion of osteolytic factors (eg, PTHrP) induced by bone-matrix-derived …

Suppressive effects of plumbagin on invasion and migration of breast cancer cells via the inhibition of STAT3 signaling and down-regulation of inflammatory cytokine …

W Yan, B Tu, Y Liu, T Wang, H Qiao, Z Zhai, H Li… - Bone research, 2013 - nature.com
Objective: The aim of this study was to investigate the effects of plumbagin (PL), a
naphthoquinone derived from the medicinal plant plumbago zeylanica, on the invasion and …

Beta-glucuronidase catalyzes deconjugation and activation of curcumin-glucuronide in bone

AG Kunihiro, PB Luis, JA Brickey, JB Frye… - Journal of natural …, 2019 - ACS Publications
The biological basis for documented in vivo bone-protective effects of turmeric-derived
curcumin is unclear since curcumin is barely detectable in serum, being rapidly conjugated …